These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Xp21/A translocation: a rarely considered genetic cause for manifesting carriers of duchenne muscular dystrophy. Trippe H; Wieczorek S; Kötting J; Kress W; Schara U Neuropediatrics; 2014 Oct; 45(5):333-5. PubMed ID: 25046452 [TBL] [Abstract][Full Text] [Related]
49. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy. McDonald CM; Henricson EK; Han JJ; Abresch RT; Nicorici A; Elfring GL; Atkinson L; Reha A; Hirawat S; Miller LL Muscle Nerve; 2010 Apr; 41(4):500-10. PubMed ID: 19941337 [TBL] [Abstract][Full Text] [Related]
50. Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy. Le Guiner C; Servais L; Montus M; Larcher T; Fraysse B; Moullec S; Allais M; François V; Dutilleul M; Malerba A; Koo T; Thibaut JL; Matot B; Devaux M; Le Duff J; Deschamps JY; Barthelemy I; Blot S; Testault I; Wahbi K; Ederhy S; Martin S; Veron P; Georger C; Athanasopoulos T; Masurier C; Mingozzi F; Carlier P; Gjata B; Hogrel JY; Adjali O; Mavilio F; Voit T; Moullier P; Dickson G Nat Commun; 2017 Jul; 8():16105. PubMed ID: 28742067 [TBL] [Abstract][Full Text] [Related]
51. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients. Jeanson-Leh L; Lameth J; Krimi S; Buisset J; Amor F; Le Guiner C; Barthélémy I; Servais L; Blot S; Voit T; Israeli D Am J Pathol; 2014 Nov; 184(11):2885-98. PubMed ID: 25194663 [TBL] [Abstract][Full Text] [Related]
52. Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. Timmons JA; Larsson O; Jansson E; Fischer H; Gustafsson T; Greenhaff PL; Ridden J; Rachman J; Peyrard-Janvid M; Wahlestedt C; Sundberg CJ FASEB J; 2005 May; 19(7):750-60. PubMed ID: 15857889 [TBL] [Abstract][Full Text] [Related]
53. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy. Hoogerwaard EM; Ginjaar IB; Bakker E; de Visser M Neurology; 2005 Dec; 65(12):1984-6. PubMed ID: 16380627 [TBL] [Abstract][Full Text] [Related]
54. Next Generation Sequencing approach to molecular diagnosis of Duchenne muscular dystrophy; identification of a novel mutation. Ebrahimzadeh-Vesal R; Teymoori A; Azimi-Nezhad M; Hosseini FS Gene; 2018 Feb; 644():1-3. PubMed ID: 29246534 [TBL] [Abstract][Full Text] [Related]
55. Diagnosis and management of Duchenne muscular dystrophy in a developing country over a 10-year period. Thong MK; Bazlin RI; Wong KT Dev Med Child Neurol; 2005 Jul; 47(7):474-7. PubMed ID: 15991868 [TBL] [Abstract][Full Text] [Related]
56. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy. Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840 [TBL] [Abstract][Full Text] [Related]
58. Duchenne/Becker muscular dystrophy in the family: have potential carriers been tested at a molecular level? Helderman-van den Enden AT; van den Bergen JC; Breuning MH; Verschuuren JJ; Tibben A; Bakker E; Ginjaar HB Clin Genet; 2011 Mar; 79(3):236-42. PubMed ID: 21070212 [TBL] [Abstract][Full Text] [Related]
59. Delays in diagnosis of Duchenne muscular dystrophy: An evaluation of genotypic and sociodemographic factors. Counterman KJ; Furlong P; Wang RT; Martin AS Muscle Nerve; 2020 Jan; 61(1):36-43. PubMed ID: 31573675 [TBL] [Abstract][Full Text] [Related]
60. Duchenne muscular dystrophy caused by a complex rearrangement between intron 43 of the DMD gene and chromosome 4. Baskin B; Gibson WT; Ray PN Neuromuscul Disord; 2011 Mar; 21(3):178-82. PubMed ID: 21134752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]